Drugmaker AbbVie is in talks to acquire privately held mental health therapeutics company Gilgamesh Pharmaceuticals in a deal worth about $1 billion, Bloomberg News reported on Wednesday, citing people familiar with the...
Natco Pharma to buy over 35% in South Africa’s Adcock Ingram
Hyderabad-based Natco Pharma on Wednesday said it has agreed to buy a 35.75% stake in Adcock Ingram, South Africa’s second-largest drugmaker, for ‘2,000 crore. The all-cash deal will give Natco Pharma a...
Brookfield, EQT close in on Gland Pharma, but rising stock a pain
Buyout groups Brookfield and EQT are in active discussions to buy Hyderabad-based Gland Pharma, a contract development and manufacturing organisation (CDMO) and injectables company, from China’s Fosun Group in what...
Torrent Pharma seeks CCI nod to acquire majority stake in JB Chemicals for Rs 19,500 crore
Ahmedabad-based Torrent Pharmaceuticals has sought fair trade regulator CCI’s clearance to acquire a majority stake in in J B Chemicals and Pharmaceuticals in a Rs 19,500-crore deal. After the completion of the...
Sino Biopharmaceutical to acquire LaNova Medicines for up to $951 million
Hong Kong-listed Sino Biopharmaceutical said on Tuesday it will buy the remaining 95.09% stake it does not hold in Shanghai-based LaNova Medicines for no more than $950.92 million. The acquisition of the cancer...
Wockhardt exits US generics biz to focus on drug discovery
Wockhardt will exit its loss-making generics business in the US as part of its strategy to enhance focus on innovation with new antibiotic drug discovery and biologics portfolio in insulin. ET was the first to report on...
Merck to acquire Verona Pharma for $10 billion
Merck will buy UK-based Verona Pharma for about $10 billion, the companies said on Wednesday, strengthening the U.S. firm’s presence in respiratory treatments as it readies for the patent expiry of its blockbuster...
Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr
Nectar Lifesciences Ltd on Tuesday said it will sell its active pharmaceutical ingredients and formulation along with menthol business assets to Ceph Lifesciences Pvt Ltd, for Rs 1,290 crore. The company has signed a...
Torrent Pharma to acquire additional 2.41% stake in JB Chemicals for Rs 620 crore
Ahmedabad-based drug maker Torrent Pharmaceuticals Ltd has signed a share purchase agreement to acquire an additional 2.41% stake in J.B. Chemicals & Pharmaceuticals Ltd from employees for a total cash consideration...
Torrent Pharma set to finalise JB Chemicals buyout in 15-18 months
Ahmedabad-based drug maker Torrent Pharmaceuticals will complete its acquisition of JB Chemicals & Pharmaceuticals in the next 15-18 months subject to key regulatory approvals, a top company executive said in an...
AbbVie to buy Capstan for up to $2.1 billion in immunology push
AbbVie said on Monday it would acquire privately held cell therapy developer Capstan Therapeutics in a deal worth up to $2.1 billion, expanding its product pipeline with experimental treatments for autoimmune diseases...
Torrent Pharma to acquire JB Chemicals at Rs 25,689 crore valuation
Ahmedabad-based drugmaker Torrent Pharma has agreed to buy a controlling stake in JB Chemicals from global private equity firm KKR at an equity valuation of Rs 25,689 crore ($3 billion). The deal, which will see a...
